549 related articles for article (PubMed ID: 18345954)
1. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
Nilsson OS
Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
[TBL] [Abstract][Full Text] [Related]
3. [External radiotherapy or non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement].
Zouhair A; Ozsahin M; Mouhsine E; Leyvraz PF; Mirimanoff RO; Coucke PA
Schweiz Med Wochenschr; 1999 Mar; 129(9):370-6. PubMed ID: 10198948
[TBL] [Abstract][Full Text] [Related]
4. Heterotopic ossification following total hip arthroplasty: a review.
Hu HP; Slooff TJ; van Horn JR
Acta Orthop Belg; 1991; 57(2):169-82. PubMed ID: 1908171
[TBL] [Abstract][Full Text] [Related]
5. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
6. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
Kjaersgaard-Andersen P; Schmidt SA
Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
[TBL] [Abstract][Full Text] [Related]
7. No migration of acetabular cups after prophylaxis for heterotopic ossification.
Ince A; Sauer U; Wollmerstedt N; Hendrich C
Clin Orthop Relat Res; 2007 Aug; 461():125-9. PubMed ID: 17415004
[TBL] [Abstract][Full Text] [Related]
8. The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty.
Board TN; Karva A; Board RE; Gambhir AK; Porter ML
J Bone Joint Surg Br; 2007 Apr; 89(4):434-40. PubMed ID: 17463108
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
10. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
[TBL] [Abstract][Full Text] [Related]
12. Heterotopic ossification in patients after total hip replacement.
Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
[TBL] [Abstract][Full Text] [Related]
13. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum.
Karunakar MA; Sen A; Bosse MJ; Sims SH; Goulet JA; Kellam JF
J Bone Joint Surg Br; 2006 Dec; 88(12):1613-7. PubMed ID: 17159174
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of heterotopic ossification following hip surgery: an update.
Pavlou G; Kyrkos M; Tsialogiannis E; Korres N; Tsiridis E
Expert Opin Pharmacother; 2012 Apr; 13(5):619-22. PubMed ID: 22404455
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
16. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
Barbato M; D'Angelo E; Di Loreto G; Menna A; Di Francesco A; Salini V; Zoppi U; Cavasinni L; La Floresta P; Romanò CL
J Orthop Traumatol; 2012 Jun; 13(2):63-7. PubMed ID: 22358779
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib and heterotopic bone formation after total hip arthroplasty.
Lavernia CJ; Contreras JS; Villa JM; Rossi MD
J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy as prevention of heterotopic ossification--preliminary results].
Miszczyk L; Spindel J; Maciejewski B; Walichiewicz P; Tarnawski R; Horzela A; Woźniak G
Przegl Lek; 2004; 61(2):61-4. PubMed ID: 15230142
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion.
Migliorini F; Asparago G; Oliva F; Cuozzo F; Maffulli N
Expert Opin Pharmacother; 2022 Jul; 23(10):1195-1203. PubMed ID: 35698796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
